Standout Papers

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emp... 2007 2026 2013 2019 659
  1. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study (2007)
    Maja Mockenhaupt, Cécile Viboud et al. Journal of Investigative Dermatology
  2. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? (2007)
    Sylvia H. Kardaun, Alexis Sidoroff et al. British Journal of Dermatology
  3. A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs (2008)
    Christine Lonjou, Nicolas Borot et al. Pharmacogenetics and Genomics

Immediate Impact

4 from Science/Nature 61 standout
Sub-graph 1 of 23

Citing Papers

Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2023 Standout
2 intermediate papers

Works of Sima Halevy being referenced

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
2007
Different Modalities of Spa Therapy for Skin Diseases at the Dead Sea Area
1998

Author Peers

Author Last Decade Papers Cites
Sima Halevy 1806 1710 3459 2132 136 5.5k
Jean‐Claude Roujeau 2386 3817 6688 4221 113 8.8k
Tetsuo Shiohara 2479 1282 4100 2793 199 8.0k
Erwin Schöpf 3481 1254 1958 1418 193 7.9k
Bernard Yu‐Hor Thong 1252 385 2338 1446 109 5.6k
J. Revuz 4453 1838 2989 1899 154 7.6k
Nikhil Yawalkar 2723 931 1445 1158 156 5.4k
Mariana Castells 1947 665 5048 2625 224 9.9k
Mayumi Ueta 879 767 2199 1358 138 4.0k
Mario Sánchez‐Borges 1804 948 2602 2468 134 6.9k
C. Juárez 802 259 1330 712 131 4.6k

All Works

Loading papers...

Rankless by CCL
2026